Recurrent ovarian dysgerminoma in pregnancy: a rare case of successful maternal and fetal outcome
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20252758Keywords:
Dysgerminoma in pregnancy, Germ cell tumor, Fetomaternal compromise, RecurrenceAbstract
Dysgerminoma is a rare malignant ovarian germ cell tumor that typically affects women younger than age 30 and is highly sensitive to chemotherapy. Its occurrence during pregnancy is uncommon and recurrence during an ongoing pregnancy is extremely rare. We report the case of a 24 years old gravida 3 para 2 woman, previously diagnosed with left ovarian dysgerminoma, who presented at 27 weeks of gestation with a recurrent left adnexal mass and splenomegaly. Imaging revealed a large, multilobulated, vascularized pelvic-abdominal mass displacing the gravid uterus, with laboratory results showing elevated tumor markers. After multidisciplinary evaluation, the pregnancy was managed conservatively until 34 weeks, when increasing maternal symptoms necessitated emergency caesarean section with staging laparotomy. A healthy infant was delivered and the mass was completely excised along with total abdominal hysterectomy and right salpingo-oophorectomy. Histopathological examination confirmed recurrent dysgerminoma and the patient was subsequently started on platinum-based chemotherapy. This case highlights the importance of individualized, multidisciplinary care and timely intervention in achieving favourable maternal and fetal outcomes in pregnancies complicated by recurrent ovarian malignancy.
Metrics
References
Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, et al. ESMO Guidelines Committee: Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;1:1-18. DOI: https://doi.org/10.1093/annonc/mdy001
Ajao M, Vachon T, Snyder P. Ovarian dysgerminoma: a case report and literature review. Mil Med. 2013;8:954-5. DOI: https://doi.org/10.7205/MILMED-D-13-00091
Cheung A, Shah S, Parker J, Soor P, Limbu A, Sheriff M, et al, Non-epithelial ovarian cancers: how much do we really know. Int J Environ Res Public Health. 2022;19:1106. DOI: https://doi.org/10.3390/ijerph19031106
Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF. Malignant germ cell tumors of the ovary. Obstet Gynecol. 2000;95:128-33. DOI: https://doi.org/10.1097/00006250-200001000-00024
Williams SD, Blessing JA, Moore DH, Homesley HD, Adcock L. Cisplatin, vinblastine and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med. 1989;1:22-7. DOI: https://doi.org/10.7326/0003-4819-111-1-22
Lee KH, Lee IH, Kim BG, Nam JH, Kim WK, Kang SB, et al. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women. Kor Gynecologic Oncol Group Study. Int J Gynecol Cancer. 2009;19:84-7. DOI: https://doi.org/10.1111/IGC.0b013e31819914c5
Karlen JR, Akbari A, Cook WA. Dysgerminoma associated with pregnancy. Obstet Gynecol. 1979;53:330-5.
Boran N, Tulunay G, Caliskan E, Köse MF, Haberal A: Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas. Arch Gynecol Obstet. 2005;271:104-8. DOI: https://doi.org/10.1007/s00404-004-0601-6
Zanetta G, Bonazzi C, Cantù M. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol. 2001;19:1015-20. DOI: https://doi.org/10.1200/JCO.2001.19.4.1015
Al Husaini H, Soudy H, Darwish AED, Ahmed M, Eltigani A, Mubarak M, et al. Pure dysgerminoma of the ovary: a single institutional experience of 65 patients. Med Oncol. 2012;29(4):2944-8 DOI: https://doi.org/10.1007/s12032-012-0194-z
Vicus D, Beiner ME, Klachook S, Le LW, Laframboise S, Mackay H. Pure dysgerminoma of the ovary 35 years on: a single institutional experience. Gynecol Oncol. 2010;117(1):23-6. DOI: https://doi.org/10.1016/j.ygyno.2009.12.024
Tangjitgamol S, Hanprasertpong J, Manusirivithaya S, Wootipoom V, Thavaramara T, Buhachat R. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes. Acta Obstet Gynecol Scand. 2010;89(2):182-9. DOI: https://doi.org/10.3109/00016340903443684
Pectasides D, Pectasides E, Kassanos D: Germ cell tumors of the ovary. Cancer Treatment Reviews. 2008;34(5):427:41. DOI: https://doi.org/10.1016/j.ctrv.2008.02.002
Tolcher MC, Fisher WE, Clark SL. Nonobstetric surgery during pregnancy. Obst Gynecol. 2018;132(2):395-403. DOI: https://doi.org/10.1097/AOG.0000000000002748
Downloads
Published
How to Cite
Issue
Section
